Follow this preprint
COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY
Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferran Torres, Víctor Moreno-Torres Concha, Itziar de Pablo López de Abechuco, Paulina García López, Francisco Abad-Santos, Clara María Rosso Fernández, Ana Aldea-Perona, Eva Montané, Ruth M. Aparicio-Hdez, Roser LLop Rius, Consuelo Pedrós, Paloma Gijón, Carolina Hernández Carballo, María José Pedrosa Martínez, Consuelo Rodríguez Jiménez, Guillermo Prada-Ramallal, Lourdes Cabrera García, Josefa Andrea Aguilar García, Rocío Sanjuan-Jimenez, Evelyn Iveth Ortiz Barraza, Enrique Sánchez-Chica, Ana Fernández-Cruz on behalf of the TOCICOV-study group
doi: https://doi.org/10.1101/2020.09.07.20189357
Now published in Infectious Diseases and Therapy doi: 10.1007/s40121-020-00373-8
Belén Ruiz-Antorán
1Clinical Pharmacology Department. Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhDAránzazu Sancho-López
1Clinical Pharmacology Department. Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhDFerran Torres
2Medical Statistics Core Facility, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic, Barcelona; Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain
MD, PhDVíctor Moreno-Torres Concha
3Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain
MDItziar de Pablo López de Abechuco
4Clinical Pharmacology Unit. Hospital Universitario Ramón y Cajal (IRYCIS). Madrid, Spain
MDPaulina García López
5Pneumology Department, Hospital Universitario Torrecardenas, Almería, Spain
MDFrancisco Abad-Santos
6Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain
MD, PhDClara María Rosso Fernández
7Unit of Clinical Pharmacology, Unit of Clinical Investigation and Clinical Trials, Hospital Universitario Virgen del Rocío, Sevilla, Spain
MD, PhDAna Aldea-Perona
8Clinical Pharmacology Department. Consorcio Parc Salut Mar. Instituto Hospital del Mar de Investigaciones Médicas (IMIM). Universidad Autónoma de Barcelona (UAB), Barcelona, Spain
MD, PhDEva Montané
9Clinical Pharmacology Department, Hospital Universitario Germans Trias i Pujol; Department of Pharmacology, Therapeutics and Toxicology, Barcelona, Spain
MD, PhDRuth M. Aparicio-Hdez
10Clinical Pharmacology Department, Hospital Universitario Central de la Defensa Gómez Ulla, Madrid, Spain
MDRoser LLop Rius
11Clinical Pharmacology Department, Hospital Universitari de Bellvitge, Barcelona, Spain
MD, PhDConsuelo Pedrós
12Clinical Pharmacology Unit, Consorci Hospital General Universitari de València, Valencia, Spain
MD, PhDPaloma Gijón
13Clinical Microbiology and Infectious Diseases Department. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
MD, PhDCarolina Hernández Carballo
14Internal Medicine Department. Hospital Universitario Nuestra Señora Candelaria, Tenerife, Spain
MD, PhDMaría José Pedrosa Martínez
15Clinical Pharmacology Department, Hospital Universitario Puerto Real, Cádiz, Spain
MD, PhDConsuelo Rodríguez Jiménez
16Clinical Pharmacology Department. Hospital Universitario de Canarias. Tenerife, España; Departamento de Medicina Física y Farmacología, Facultad de Medicina, Universidad de La Laguna (ULL), Tenerife, Spain
MD, PhDGuillermo Prada-Ramallal
17Epidemiology, Statistics and Research Methodology Unit. Institute for Health Research Foundation (FIDIS). Santiago de Compostela, Spain
MD, PhDLourdes Cabrera García
18Clinical Pharmacology Department. Hospital Universitario Clínico San Carlos, Madrid, Spain
MDJosefa Andrea Aguilar García
19Internal Medicine Department. Hospital Costa del Sol Marbella, Málaga, Spain
MD, PhDRocío Sanjuan-Jimenez
20UICEC IBIMA, Plataforma SCReN; Servicio de Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Málaga, España
MD, PhDEvelyn Iveth Ortiz Barraza
21Internal Medicine Department. Hospital Universitario Ramón y Cajal (IRYCIS). Madrid. Spain
MDEnrique Sánchez-Chica
3Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain
MDAna Fernández-Cruz
22Infectious Diseases Unit. Internal Medicine Department. Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhD
Data Availability
Data sharing: After publication, the data will be made available to others on reasonable requests to the corresponding authors. A proposal with a detailed description of study objectives and statistical analysis plan will be needed for evaluation of the reasonability of requests. Additional materials might also be required during the process of evaluation. De-identified participant data will be provided after approval from the principal researchers of the Hospital Puerta de Hierro-Majadahonda.
Posted September 10, 2020.
COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY
Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferran Torres, Víctor Moreno-Torres Concha, Itziar de Pablo López de Abechuco, Paulina García López, Francisco Abad-Santos, Clara María Rosso Fernández, Ana Aldea-Perona, Eva Montané, Ruth M. Aparicio-Hdez, Roser LLop Rius, Consuelo Pedrós, Paloma Gijón, Carolina Hernández Carballo, María José Pedrosa Martínez, Consuelo Rodríguez Jiménez, Guillermo Prada-Ramallal, Lourdes Cabrera García, Josefa Andrea Aguilar García, Rocío Sanjuan-Jimenez, Evelyn Iveth Ortiz Barraza, Enrique Sánchez-Chica, Ana Fernández-Cruz
medRxiv 2020.09.07.20189357; doi: https://doi.org/10.1101/2020.09.07.20189357
Now published in Infectious Diseases and Therapy doi: 10.1007/s40121-020-00373-8
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (218)
- Cardiovascular Medicine (3219)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13236)
- Forensic Medicine (19)
- Gastroenterology (889)
- Genetic and Genomic Medicine (5056)
- Geriatric Medicine (469)
- Health Economics (772)
- Health Informatics (3180)
- Health Policy (1127)
- Hematology (423)
- HIV/AIDS (999)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4802)
- Nursing (254)
- Nutrition (715)
- Oncology (2474)
- Ophthalmology (701)
- Orthopedics (278)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1276)
- Primary Care Research (550)
- Public and Global Health (7364)
- Radiology and Imaging (1668)
- Respiratory Medicine (967)
- Rheumatology (473)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (231)
- Urology (199)